Thyrocare Technologies Limited has informed the Exchange that Board of Directors at its meeting held on April 23, 2025, recommended Final Dividend of Rs. 21 per equity share.
THYROCARE · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 8.4 pts more than Nifty Microcap 250 and 9.1 pts more than its Healthcare Service Provider peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
The Board of Directors of Thyrocare Technologies Limited, at its meeting held on April 23, 2025, has recommended a Final Dividend of Rs. 21 per equity share for its shareholders. This is the dividend amount recommended by the Board, which will be subject to approval by shareholders at the upcoming Annual General Meeting. The record date and book closure dates would typically be announced separately by the company. The final dividend represents a direct payout to shareholders from the company's profits.
This is a positive signal for shareholders as it indicates the company is generating profits and returning value to investors. The actual yield will depend on the current share price, but a Rs. 21 per share payout is a meaningful cash return for equity holders.